Free tool
Drug Trial Radar: Endocrinology and women's health
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Active, not recruiting, industry sponsors, Endocrinology and women's health, Phase 1
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed172
2 trials
Showing 1 to 2, recently updated first.
- Study Evaluating ABCL635 for Vasomotor Symptoms of MenopausePivotal-lookingActive, not recruiting
AbCellera Biologics Inc.Industry
NCT07118891 · 136 participants (planned) · Start Jun 23, 2025 · Primary completion Feb 2027
Drug: ABCL635; Placebo · For: Vasomotor Symptoms Associated With Menopause; Healthy Volunteers
Sites: Calgary, Canada; Red Deer, Canada; Vancouver, Canada · 13 sites in all
- Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of FractureActive, not recruiting
HELP Therapeutics Co., Ltd.Industry
NCT06949137 · 9 participants · Start Jun 20, 2025 · Primary completion Mar 6, 2026
Drug: Human Umbilical Cord-derived Mesenchymal stem cell · For: Osteoporosis in Post-menopausal Women; Osteoporosis
Sites: Nanjing, China
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.